Ultragenyx Pharmaceutical said on Monday that late-stage studies showed its drug for a type of genetic bone disease failed to ...

HOW TO TAKE THE POST-TEST: To obtain CME credit, please click here after reading the article to take the post-test on myCME.com. Organ transplantation has become a fairly common and effective modality ...

With a pair of Phase III trial flops, Ultragenyx will explore cost reductions as analysts turn attention to an upcoming ...

Findings may help develop faster-healing treatments for Perthes and similar bone conditionsDallas, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Researchers at Scottish Rite for Children received a $2.3 million, ...

When we think about health check-ups before 50, heart health, blood sugar, and cholesterol often top the list. Bone health, ...

Brittle bone disease (osteogenesis imperfecta) is an inherited genetic condition that causes bone weakness. It can increase a person’s risk of fractures and other medical complications. A person with ...

Dear Doctors: I was recently diagnosed with Paget’s disease after suffering fatigue symptoms and muscle soreness in my neck, pelvic and lower-leg areas. I am sore and lethargic upon waking up in the ...

Ultragenyx Pharmaceutical and Mereo BioPharma said their two Phase 3 trials for setrusumab to treat rare bone disorder osteogenesis imperfecta, didn't meet their main goal of reducing fracture rates.

The interplay between bone and cardiovascular systems represents a dynamic and rapidly expanding field of biomedical research. Scientific advances have ...

Here’s a DIY prescription for women looking to do everything they can to prevent a broken hip: Drink tea, not coffee.